Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Radiology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Clin Rheumatol. 2020 Apr;39(4):1223-1228. doi: 10.1007/s10067-019-04872-z. Epub 2019 Dec 18.
To describe the pattern of pulmonary artery vasculitis and the characteristic computed tomographic pulmonary angiography (CTPA) signs in patients with Hughes-Stovin syndrome (HSS). In a retrospective study, the medical records of eight HSS patients (six men), seen between February 2008 and January 2018, were reviewed regarding history, disease characteristics, laboratory investigations, imaging, and treatments. The mean (SD) age was 37.375 ± 8.65 years (range 30-55) and mean (SD) follow-up 30 ± 41.60 months (range 9-132). In all patients, routine laboratory investigations and complete coagulation profile were done. In all, CTPA studies were performed as well as and Doppler ultrasound for suspected deep vein thrombosis (DVT). Four patients had a history of thrombophlebitis, and DVT was observed in all, in two cases bilateral. Arterial thromboses involving popliteal, tibial, common iliac, and femoral arteries were observed in one patient. All patients had mild to moderate hemoptysis, and one had massive hemoptysis. None of the patients had a history of recurrent mouth and/or genital ulcers, uveitis, or arthritis. In all patients, CTPA identified bilateral pulmonary artery aneurysms (PAAs) with adherent in situ thrombosis and mural enhancement in all patients. Lobar PA branches were involved in all patients, segmental in six and main PA in five patients. Proper immunomodulators were initiated early, with favorable outcome; none was treated with TNF-α antagonists. HSS is a systemic vasculitis that may affect virtually all major veins and arteries in patients with normal coagulation profile. PAAs, adherent in situ thrombosis, and mural wall enhancement are characteristic CTPA signs. Early treatment with immunomodulators is essential.Key Points• Hughes Stevin syndrome (HSS) is a systemic vasculitis that may affect virtually all major veins and arteries in patients. It has a normal coagulation profile.• Computed tomography (CT) pulmonary angiography is considered to be the most important diagnostic tool to assess the degree and the extent of the characteristic pulmonary artery aneurysms, and in situ thrombosis, and mural wall enhancement.• It is likely that HSS syndrome is often not recognized and misdiagnosed as deep venous thrombosis (DVT) with pulmonary thromboembolism.• Early treatment with combined immunomodulators is essential to ensure favorable outcome.
描述 Hughes-Stovin 综合征(HSS)患者肺动脉血管炎的模式和特征性 CT 肺动脉造影(CTPA)征象。在一项回顾性研究中,回顾了 2008 年 2 月至 2018 年 1 月期间就诊的 8 例 HSS 患者(6 名男性)的病历,包括病史、疾病特征、实验室检查、影像学检查和治疗情况。患者的平均年龄(标准差)为 37.375 ± 8.65 岁(范围 30-55 岁),平均(标准差)随访时间为 30 ± 41.60 个月(范围 9-132 个月)。所有患者均进行了常规实验室检查和全面凝血谱检查。所有患者均行 CTPA 检查,疑似深静脉血栓形成(DVT)时行多普勒超声检查。4 例患者有血栓性静脉炎病史,均观察到 DVT,其中 2 例为双侧。1 例患者出现累及腘动脉、胫前动脉、髂总动脉和股动脉的动脉血栓形成。所有患者均有轻至中度咯血,1 例有大咯血。所有患者均无复发性口腔和/或生殖器溃疡、葡萄膜炎或关节炎病史。所有患者的 CTPA 均显示双侧肺动脉瘤(PAA),均有附壁原位血栓形成和壁强化。所有患者均累及叶肺动脉分支,6 例累及段肺动脉,5 例累及主肺动脉。早期应用适当的免疫调节剂进行治疗,效果良好;均未使用 TNF-α 拮抗剂治疗。HSS 是一种系统性血管炎,几乎可影响所有正常凝血谱患者的所有主要静脉和动脉。PAA、附壁原位血栓形成和壁强化是 CTPA 的特征性征象。早期应用免疫调节剂治疗至关重要。
Hughes-Stovin 综合征(HSS)是一种系统性血管炎,几乎可影响所有正常凝血谱患者的所有主要静脉和动脉。
CT 肺动脉造影被认为是评估特征性肺动脉瘤、原位血栓形成和壁强化程度和范围的最重要诊断工具。
可能由于 Hughes-Stovin 综合征常常未被识别并误诊为伴有肺血栓栓塞症的深静脉血栓形成(DVT)。
早期联合应用免疫调节剂治疗对于确保良好的治疗效果至关重要。